BRIEF published on 05/14/2024 at 22:15, 4 months 4 days ago GENFIT Announces Q1 2024 Financials and Projects Cash Runway into Late 2025 Cash Position Clinical Trials Revenue Decline Biopharmaceutical Industry GENFIT Financial Results
BRIEF published on 05/14/2024 at 22:15, 4 months 4 days ago GENFIT annonce ses résultats financiers du premier trimestre 2024 et dispose d'une trésorerie disponible jusqu'à fin 2025 Industrie Biopharmaceutique Essais Cliniques Baisse Des Revenus Résultats Financiers De GENFIT Situation De Trésorerie
PRESS RELEASE published on 05/14/2024 at 22:10, 4 months 4 days ago GENFIT : Information financière du premier trimestre 2024 GENFIT annonce sa situation de trésorerie au 31 mars 2024 et son chiffre d'affaires du premier trimestre 2024, avec des revenus en baisse par rapport à 2023 Chiffre D'affaires Biopharmaceutique Trésorerie Maladies Rares GENFIT
PRESS RELEASE published on 05/14/2024 at 22:10, 4 months 4 days ago GENFIT Reports First Quarter 2024 Financial Information GENFIT reports Q1 2024 financial information showing cash position of €74.0 million and revenues of €1.1 million. Company expects cash to fund operations until Q4 2025 Financial Information Revenues Cash Position Q1 2024 GENFIT
Published on 09/18/2024 at 23:10, 3 hours 7 minutes ago Ur-Energy Provides Operations, Construction and 2024 Guidance Updates
Published on 09/18/2024 at 23:00, 3 hours 17 minutes ago Garden State Gold & Coin Applauds Passage of Historic NJ Sales Tax Bill on Precious Metals
Published on 09/18/2024 at 21:15, 5 hours 2 minutes ago New to the Street Launches 24-Part Series with ARAX Holdings, Spotlighting Core Blockchain, CorePass, Lunaº Mesh, and Revolutionary Tech Solutions
Published on 09/18/2024 at 21:00, 5 hours 17 minutes ago Falcon Commences Drilling At Its Great Burnt Copper Project, NL
Published on 09/18/2024 at 16:30, 9 hours 47 minutes ago Manimal Tales Launches New Nursery Rhyme Based Detective Series: Your Child Solves Nursery Crimes in our Newest Personalized Book!
Published on 09/18/2024 at 19:11, 7 hours 6 minutes ago EQS-Adhoc: alstria office REIT-AG: squeeze-out demand regarding the shares of minority shareholders, amendment to investment agreement, loss of REIT-status at year-end 2024
Published on 09/18/2024 at 18:45, 7 hours 32 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/18/2024 at 18:31, 7 hours 45 minutes ago EQS-Adhoc: Vonovia SE: Initiation of the process to conclude a domination and profit and loss transfer agreement between Vonovia SE and Deutsche Wohnen SE
Published on 09/18/2024 at 18:13, 8 hours 4 minutes ago BILENDI: Creating discussion guides for market research is now possible with AI, thanks to BARI and Bilendi Discuss
Published on 09/18/2024 at 17:21, 8 hours 55 minutes ago EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 154,053 no-par value bearer shares at an issue price of EUR 5 per share
Published on 09/18/2024 at 18:45, 7 hours 31 minutes ago Augmentation de capital consécutive à l'attribution gratuite d'actions aux salariés du groupe EuropaCorp
Published on 09/18/2024 at 18:45, 7 hours 31 minutes ago Capital increase following the allocation of free shares to EuropaCorp employees
Published on 09/18/2024 at 17:40, 8 hours 37 minutes ago Groupe CRIT : Modalités de mise à disposition du Rapport Financier semestriel 2024.